Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Kristanc L et al. | Effects of the pore-forming agent nystatin on giant phospholipid vesicles. | 2012 | Biochim. Biophys. Acta | pmid:22178865 |
Adetutu EM et al. | Impact of bacterial and fungal processes on 14C-hexadecane mineralisation in weathered hydrocarbon contaminated soil. | 2012 | Sci. Total Environ. | pmid:22154183 |
Kaufman DA | "Getting to Zero": preventing invasive Candida infections and eliminating infection-related mortality and morbidity in extremely preterm infants. | 2012 | Early Hum. Dev. | pmid:22633513 |
Khan MA et al. | Immune stimulating and therapeutic potential of tuftsin-incorporated nystatin liposomes against Cryptococcus neoformans in leukopenic BALB/C mice. | 2012 | FEMS Immunol. Med. Microbiol. | pmid:22612788 |
Martins HP et al. | Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species. | 2012 | Acta Derm. Venereol. | pmid:21918792 |
Usta Y | Persistent hiccups: an unusual presentation and treatment. | 2012 | J Pain Symptom Manage | pmid:22248794 |
Di Capua R et al. | Towards the realization of label-free biosensors through impedance spectroscopy integrated with IDES technology. | 2012 | Eur. Biophys. J. | pmid:22237602 |
Gerstein AC et al. | Parallel genetic changes and nonparallel gene-environment interactions characterize the evolution of drug resistance in yeast. | 2012 | Genetics | pmid:22714405 |
Bzik VA et al. | Mechanisms of action of zinc on rat intestinal epithelial electrogenic ion secretion: insights into its antidiarrhoeal actions. | 2012 | J. Pharm. Pharmacol. | pmid:22471360 |
Baugé C et al. | Regulatory mechanism of transforming growth factor beta receptor type II degradation by interleukin-1 in primary chondrocytes. | 2012 | Biochim. Biophys. Acta | pmid:22425785 |
Semis R et al. | Pharmacokinetics, tissue distribution and immunomodulatory effect of intralipid formulation of nystatin in mice. | 2012 | J. Antimicrob. Chemother. | pmid:22499997 |
Leibovitz E | Strategies for the prevention of neonatal candidiasis. | 2012 | Pediatr Neonatol | pmid:22503254 |
Bhattacharya S et al. | DNA conjugated SWCNTs enter endothelial cells via Rac1 mediated macropinocytosis. | 2012 | Nano Lett. | pmid:22375622 |
Tester R et al. | The use of konjac glucomannan hydrolysates to recover healthy microbiota in infected vaginas treated with an antifungal agent. | 2012 | Benef Microbes | pmid:22348910 |
Jolivot PA et al. | [Assessment of in vitro activity and stability of antifungal suspensions for mouthrinses: to a reappraisal of empiric practices?]. | 2012 | Pathol. Biol. | pmid:22361161 |
Lee MJ et al. | Structural analysis and biosynthetic engineering of a solubility-improved and less-hemolytic nystatin-like polyene in Pseudonocardia autotrophica. | 2012 | Appl. Microbiol. Biotechnol. | pmid:22382166 |
Pontes HA et al. | Oral candidiasis mimicking an oral squamous cell carcinoma: report of a case. | 2012 | Gerodontology | pmid:20633054 |
Kovac M et al. | Miconazole and nystatin used as topical antifungal drugs interact equally strongly with warfarin. | 2012 | J Clin Pharm Ther | pmid:21332566 |
Bakhshi M et al. | Comparison of therapeutic effect of aqueous extract of garlic and nystatin mouthwash in denture stomatitis. | 2012 | Gerodontology | pmid:22126338 |
Santos KK et al. | Anti-Candida activity of Mentha arvensis and Turnera ulmifolia. | 2012 | J Med Food | pmid:22082100 |
Ocerin-Guerra I et al. | Nystatin-induced acute generalized exanthematous pustulosis. | 2012 | Actas Dermosifiliogr | pmid:23149047 |
Kumar R et al. | A new antifungal coumarin from Clausena excavata. | 2012 | Fitoterapia | pmid:22088496 |
Castón JJ et al. | [Clinical factors associated with invasive pulmonary aspergillosis in patients with chronic pneumopathies and respiratory isolation of Aspergillus spp]. | 2012 | Med Clin (Barc) | pmid:23103103 |
Matsubara VH et al. | Treatment with probiotics in experimental oral colonization by Candida albicans in murine model (DBA/2). | 2012 | Oral Dis | pmid:22059932 |
Seipke RF et al. | Isolating antifungals from fungus-growing ant symbionts using a genome-guided chemistry approach. | 2012 | Meth. Enzymol. | pmid:23084933 |
Kaczorowska-Hac B et al. | Methemoglobinemia in postchemotherapy stomatitis topical treatment: 2 pediatric cases. | 2012 | J. Pediatr. Hematol. Oncol. | pmid:21900833 |
Agwu E et al. | Distribution of yeast species associated with oral lesions in HIV-infected patients in Southwest Uganda. | 2012 | Med. Mycol. | pmid:21905950 |
Bulacio L et al. | Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility. | 2012 | J Mycol Med | pmid:23518170 |
Yang Y et al. | A chloroplast envelope membrane protein containing a putative LrgB domain related to the control of bacterial death and lysis is required for chloroplast development in Arabidopsis thaliana. | 2012 | New Phytol. | pmid:21916894 |
Noss MR and Cha J | Erythematous penile lesion. | 2012 | J Fam Pract | pmid:23313994 |
Giglio M et al. | Oral nystatin prophylaxis in surgical/trauma ICU patients: a randomised clinical trial. | 2012 | Crit Care | pmid:22490643 |
Xu L et al. | Epirubicin enhances TRAIL-induced apoptosis in gastric cancer cells by promoting death receptor clustering in lipid rafts. | 2011 May-Jun | Mol Med Rep | pmid:21468584 |
Brito GN et al. | In vitro antifungal susceptibility of Candida spp. oral isolates from HIV-positive patients and control individuals. | 2011 Jan-Feb | Braz Oral Res | pmid:21271179 |
Berger J et al. | Evidence for basolateral Cl- channels as modulators of apical Cl- secretion in pulmonary epithelia of Xenopus laevis. | 2011 | Am. J. Physiol. Regul. Integr. Comp. Physiol. | pmid:21123756 |
Day TP et al. | Imbuing aqueous solubility to amphotericin B and nystatin with a vitamin. | 2011 | Mol. Pharm. | pmid:21141891 |
El-Ridy MS et al. | Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin. | 2011 | Drug Dev Ind Pharm | pmid:21707323 |
Zerbib C et al. | One-pot synthesis of a new antifungal polymerisable monomer and its characterisation by coordination-ion spray mass spectrometry. | 2011 | Rapid Commun. Mass Spectrom. | pmid:21710593 |
Huang CY et al. | Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus successfully treated by oral voriconazole and nystatin packing. | 2011 | Mycopathologia | pmid:21424606 |
Mane RS et al. | Synthesis of an adenine nucleoside containing the (8'R) epimeric carbohydrate core of amipurimycin and its biological study. | 2011 | J. Org. Chem. | pmid:21381774 |
Woods O and Saliba I | Effect of nystatin on Guinea Pigs' inner ear. | 2011 | Neurotox Res | pmid:21384237 |
Kodedová M et al. | Fluorescence method for determining the mechanism and speed of action of surface-active drugs on yeast cells. | 2011 | BioTechniques | pmid:21231924 |
Stewart AK et al. | Functional characterization and modified rescue of novel AE1 mutation R730C associated with overhydrated cation leak stomatocytosis. | 2011 | Am. J. Physiol., Cell Physiol. | pmid:21209359 |
Orce G et al. | β-Cyclodextrin and permeability to water in the bladder of Bufo arenarum. | 2011 | Can. J. Physiol. Pharmacol. | pmid:21609275 |
Messier C and Grenier D | Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans. | 2011 | Mycoses | pmid:21615543 |
Acar A et al. | Comparison of silver-coated dressing (Acticoat®), chlorhexidine acetate 0.5% (Bactigrass®) and nystatin for topical antifungal effect in Candida albicans-contaminated, full-skin-thickness rat burn wounds. | 2011 | Burns | pmid:21354707 |
Mayercik VA et al. | Fungal endophthalmitis developing in asthmatic individuals treated with inhaled corticosteroids. | 2011 | Arch. Ophthalmol. | pmid:21746988 |
Pendela M et al. | Simultaneous determination of lidocaine hydrochloride, hydrocortisone and nystatin in a pharmaceutical preparation by RP-LC. | 2011 | J Pharm Biomed Anal | pmid:21794999 |
Yamasaki M et al. | Effects and mechanisms of action of polyene macrolide antibiotic nystatin on Babesia gibsoni in vitro. | 2011 | J. Parasitol. | pmid:21756054 |
Valitova JN et al. | Effects of sterol-binding agent nystatin on wheat roots: the changes in membrane permeability, sterols and glycoceramides. | 2011 | Phytochemistry | pmid:21726881 |
Ebert S et al. | Candida esophagitis as the cause of swallowing disturbances in an 85-year-old patient with myasthenia gravis. | 2011 | Z Gerontol Geriatr | pmid:21732154 |